
               
               
               CLINICAL PHARMACOLOGY
               
                  The mechanism of action of maprotiline is not precisely known. It does not act primarily by stimulation of the central nervous system and is not a monoamine oxidase inhibitor. The postulated mechanism of maprotiline is that it acts primarily by potentiation of central adrenergic synapses by blocking reuptake of norepinephrine at nerve endings. This pharmacologic action is thought to be responsible for the drug's antidepressant and anxiolytic effects.
                  The mean time to peak is 12 hours. The half-life of elimination averages 51 hours.
                  Steady-state levels measured prior to the morning dose on a one dosage regimen are summarized as follows:
                  


